13F filer · CIK 1482416
Sio Capital Management, LLC
NEW YORK, NY · filing since Q4 2014 · last filing Aug 14, 2026
Reported value
$604.3M
$-93.0M vs prior
Positions
59
New / sold out
17 / 34
Added / reduced
10 / 21
Turnover
34.8%
buys $226.6M · sells $360.7M
Top-10 weight
48.6%
Biggest buys vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| New | ALLOGENE THERAPEUTICS INC | +13,323,431 | – | +$27.7M |
| New | GLOBUS MED INC | +301,816 | – | +$23.8M |
| Added | CENCORA INC | +72,694 | +72.0% | +$20.6M |
| New | SELLAS LIFE SCIENCES GROUP IPUT | +1,230,700 | – | +$18.2M |
| New | IDEAYA BIOSCIENCES INC | +480,383 | – | +$17.9M |
| New | THE CIGNA GROUP | +57,750 | – | +$15.9M |
| New | VIATRIS INC | +954,299 | – | +$15.2M |
| New | REGENERON PHARMACEUTICALS | +18,000 | – | +$11.2M |
| New | BRISTOL-MYERS SQUIBB CO | +193,500 | – | +$11.1M |
| New | MEDTRONIC PLC | +142,500 | – | +$11.1M |
17 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Biggest sells vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Reduced | ICON PUB LTD CO | -218,172 | -71.2% | $-37.9M |
| Reduced | DIANTHUS THERAPEUTICS INC | -310,791 | -84.0% | $-30.3M |
| Sold out | CORCEPT THERAPEUTICS INC | -674,759 | -100.0% | $-27.2M |
| Sold out | LIVANOVA PLC | -421,615 | -100.0% | $-26.8M |
| Sold out | EMBECTA CORP | -1,847,850 | -100.0% | $-16.3M |
| Sold out | ABIVAX SA | -135,800 | -100.0% | $-15.1M |
| Reduced | WAYSTAR HLDG CORP | -716,402 | -43.6% | $-14.7M |
| Reduced | ANI PHARMACEUTICALS INC | -168,238 | -63.4% | $-13.9M |
| Sold out | HAEMONETICS CORP MASS | -220,672 | -100.0% | $-12.4M |
| Sold out | TELEFLEX INCORPORATED | -94,800 | -100.0% | $-11.3M |
45 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | ANTERIS TECHNOLOGIES GLOBALCOM | 5,545,984 | $54.6M | 9.04% |
| 2 | CENCORA INCCOM | 173,588 | $49.1M | 8.13% |
| 3 | MAXIMUS INCCOM | 715,267 | $38.5M | 6.36% |
| 4 | ALLOGENE THERAPEUTICS INCCOM | 13,323,431 | $27.7M | 4.59% |
| 5 | GLOBUS MED INCCL A | 301,816 | $23.8M | 3.95% |
| 6 | GSK PLCSPONSORED ADR | 436,700 | $22.9M | 3.79% |
| 7 | TYRA BIOSCIENCES INCCOM | 695,315 | $22.2M | 3.68% |
| 8 | WAYSTAR HLDG CORPCOM | 925,834 | $19.0M | 3.15% |
| 9 | SELLAS LIFE SCIENCES GROUP IPUTCOM NEW | 1,230,700 | $18.2M | 3.01% |
| 10 | IDEAYA BIOSCIENCES INCCOM | 480,383 | $17.9M | 2.96% |
49 more rows. Subscribe for $29/month to see every row, download the data and use the API.